About HKTDC | Media Room | Contact HKTDC | Wish List Wish List () | My HKTDC |
Save As PDF Print this page
Qzone

DEA Restricts Imports of Synthetic Cannabinoids

The U.S. Drug Enforcement Administration has announced its intent to issue an order temporarily including the following synthetic cannabinoids (and their optical, positional and geometric isomers, salts and salts of isomers) into schedule I of the Controlled Substances Act. The temporary scheduling order has the effect of imposing the regulatory requirements under the CSA on the importation, exportation, manufacture, distribution, reverse distribution, possession, research and conduct of instructional activities, and chemical analysis of these substances, as well as the administrative, civil and criminal penalties that apply to persons who fail to comply with such requirements or otherwise violate the CSA with respect to these substances.

This order will be effective on 10 July and remain in place for two years, with a possible extension of one year. Affected products are:

  • naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate
  • N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide
  • 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide
  • methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate
  • 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide
Content provided by Picture: HKTDC Research
Comments (0)
Shows local time in Hong Kong (GMT+8 hours)

HKTDC welcomes your views. Please stay on topic and be respectful of other readers.
Review our Comment Policy

*Add a comment (up to 5,000 characters)